Shenzhen Chipscreen Biosciences Co., Ltd. — Investor Relations & Filings
Shenzhen Chipscreen Biosciences Co., Ltd. specializes in the discovery and development of original small molecule innovative drugs. The company leverages its proprietary chemical genomics-based drug discovery and early evaluation platform to address unmet medical needs in oncology, metabolic diseases, and autoimmune disorders. Its portfolio includes Chidamide (Epidaza), a selective histone deacetylase (HDAC) inhibitor approved for peripheral T-cell lymphoma and advanced breast cancer, and Chiglitazar (Bilessyl), a novel PPAR pan-agonist for type 2 diabetes. Chipscreen Biosciences maintains an integrated R&D system covering drug discovery, clinical development, and commercialization, focusing on molecular mechanisms and translational medicine to provide novel therapeutic solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于收到国家知识产权局《无效宣告请求审查决定书》的公告 | 2026-05-08 | Chinese | |
| 国投证券股份有限公司关于深圳微芯生物科技股份有限公司差异化分红事项的核查意见 | 2026-05-07 | Chinese | |
| 2025年年度权益分派实施公告 | 2026-05-07 | Chinese | |
| 关于实施2025年年度权益分派调整“微芯转债”转股价格暨转股复牌的公告 | 2026-05-07 | Chinese | |
| 关于2025年年度权益分派实施后调整回购价格上限的公告 | 2026-05-07 | Chinese | |
| 关于股份回购进展公告 | 2026-05-06 | Chinese |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44488403 | 关于收到国家知识产权局《无效宣告请求审查决定书》的公告 | 2026-05-08 | Chinese | ||
| 44272506 | 国投证券股份有限公司关于深圳微芯生物科技股份有限公司差异化分红事项的核查意见 | 2026-05-07 | Chinese | ||
| 44269807 | 2025年年度权益分派实施公告 | 2026-05-07 | Chinese | ||
| 44269803 | 关于实施2025年年度权益分派调整“微芯转债”转股价格暨转股复牌的公告 | 2026-05-07 | Chinese | ||
| 44265242 | 关于2025年年度权益分派实施后调整回购价格上限的公告 | 2026-05-07 | Chinese | ||
| 44277685 | 关于股份回购进展公告 | 2026-05-06 | Chinese | ||
| 39049015 | 国投证券股份有限公司关于深圳微芯生物科技股份有限公司2025年度募集资金存放、管理与实际使用情况的核查意见 | 2026-03-30 | Chinese | ||
| 39049013 | 关于使用自有资金、银行承兑汇票等方式支付募投项目所需资金并以募集资金等额置换的公告 | 2026-03-30 | Chinese | ||
| 39048995 | 2025年度“提质增效重回报”行动方案年度评估报告暨2026年度“提质增效重回报”专项行动方案 | 2026-03-30 | Chinese | ||
| 39048994 | 国投证券股份有限公司关于深圳微芯生物科技股份有限公司使用自有资金、银行承兑汇票等方式支付募投项目所需资金并以募集资金等额置换的核查意见 | 2026-03-30 | Chinese | ||
| 39048983 | 2025年度环境、社会和公司治理报告 (ESG) 摘要 | 2026-03-30 | Chinese | ||
| 39048974 | 关于使用自有资金进行现金管理的公告 | 2026-03-30 | Chinese | ||
| 39048959 | 2025年年度报告摘要 | 2026-03-30 | Chinese | ||
| 39048957 | 2025年度独立董事述职报告（王艳梅） | 2026-03-30 | Chinese | ||
| 39048946 | 第三届董事会第二十五次会议决议公告 | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Shenzhen Chipscreen Biosciences Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58336/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58336 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58336 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58336 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58336}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shenzhen Chipscreen Biosciences Co., Ltd. (id: 58336)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.